Abstract
Acute pulmonary embolism (APE) is a thromboembolism situation that can be central or peripheral. APE risk analysis and classification are essential for therapy planning. Our aim is to determine the novel MAPH score (including age, mean platelet volume (MPV), total protein, and hematocrit parameters) that can distinguish APE subtypes. Our retrospective cohort analysis includes 97 APE patients referred to the emergency medicine department who underwent pulmonary computed tomography angiography (CTA) in 24 h from 2020 to 2022. The hospital information system provided demographic, clinical, laboratory, and pulmonary CTA data. APE was classified into central (46 patients) and peripheral (51 patients) depending on the area of vascular involvement. The central APE group had higher hypertension (HT) (67.4%) and atrial fibrillation (AF) (39.1%) incidence than the peripheral APE group (all p values > 0.05). The central APE had higher total protein and platelet counts (p = 0.003 and p = 0.036), but peripheral APE had higher troponin values (p = 0.029). Central APE had 2.17 ± 0.85 MAPH and peripheral APE 1.76 ± 0.95 (p = 0.029). HT, AF, platelet count, and MAPH score differed significantly in univariate logistic regression (all p values < 0.05). However, only platelet count varied in multivariate logistic regression (p = 0.042). ROC curve analysis revealed that the MAPH score predicts central APE with 83% sensitivity and 45% specificity at a cut-off level of 1.5. The new MAPH score as an indicator of blood viscosity may distinguish between central and peripheral APE. Our result is significant, especially for centers with limited examinations, as it may accelerate the diagnosis and treatment processes. We think that our results might guide future investigations.
Similar content being viewed by others
Data availability
All data and analyses related to our study can be accessed at a reasonable request from the corresponding author.
References
Konstantinides SV, Meyer G, Becattini C, ESC Scientific Document Group et al (2020) ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 41(4):543–603
Raskob GE, Angchaisuksiri P, Blanco AN et al (2014) Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 34:23632371
Pollack CV, Schreiber D, Goldhaber SZ et al (2011) Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol 57:700706
Wendelboe AM, Raskob GE (2016) Global burden of thrombosis: epidemiologic aspects. Circ Res 118:13401347
Keller K, Hobohm L, Ebner M et al (2020) Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J 41:522529
de Miguel-Diez J, Jimenez-Garcia R, Jimenez D et al (2014) Trends in hospital admissions for pulmonary embolism in Spain from 2002 to 2011. Eur Respir J 44:942950
Dentali F, Ageno W, Pomero F et al (2016) Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy. Thromb Haemost 115(2):399–405
Lehnert P, Lange T, Moller CH et al (2018) Acute pulmonary embolism in a national Danish cohort: increasing incidence and decreasing mortality. Thromb Haemost 118:539546
Lutsey PL, Zakai NA (2023) Epidemiology and prevention of venous thromboembolism. Nat Rev Cardiol 20(4):248–262
Cimini LA, Candeloro M, Pływaczewska M et al (2023) Prognostic role of different findings at echocardiography in acute pulmonary embolism: a critical review and meta-analysis. ERJ Open Res 9(2):00641–02022
Barco S, Valerio L, Gallo A et al (2021) Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: vital registration data from 123 countries. Res Pract Thromb Haemost 5(5):e12520
Leonhardi J, Bailis N, Lerche M et al (2023) Computed tomography embolus texture analysis as a prognostic marker of acute pulmonary embolism. Angiology 74(5):461–471
Albrecht MH, Bickford MW, Nance JW Jr et al (2017) State-of-the-art pulmonary CT angiography for acute pulmonary embolism. Am J Roentgenol 208:495–504
Bae JY, Murugiah K (2023) Invasive pulmonary angiogram performance and interpretation in the diagnosis of pulmonary thromboembolic disease. Interv Cardiol Clin 12(3):299–307
Alonso Martinez JL, Anniccherico Sánchez FJ, Urbieta Echezarreta MA et al (2016) Central versus peripheral pulmonary embolism: analysis of the impact on the physiological parameters and long-term survival. N Am J Med Sci 8(3):134–142
Kumar A, Cannon CP (2009) Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc 84(10):917–938
Koupenova M, Kehrel BE, Corkrey HA et al (2017) Thrombosis and platelets: an update. Eur Heart J 38(11):785–791
Weisel JW, Litvinov RI (2019) Red blood cells: the forgotten player in hemostasis and thrombosis. J Thromb Haemostasis 17(2):271–282
Hammons L, Filopei J, Steiger D et al (2019) A narrative review of red blood cell distribution width as a marker for pulmonary embolism. J Thromb Thrombolysis 48(4):638–647
Aleman MM, Walton BL, Byrnes JR et al (2014) Fibrinogen and red blood cells in venous thrombosis. Thromb Res 133:S38-40
Atici AG, Kayhan S, Aydin D et al (2013) Plasma viscosity levels in pulmonary thromboembolism. Clin Hemorheol Microcirc 55(3):313–320
Stępień K, Ząbczyk M, Kopytek M et al (2023) Reduced fibrin clot permeability on admission and elevated E-selectin at 3 months as novel risk factors of residual pulmonary vascular obstruction in patients with acute pulmonary embolism. J Thromb Thrombolysis. https://doi.org/10.1007/s11239-023-02901-y
Babaoglu E, Ulasli SS (2023) Clinical importance of red cell distribution width and red cell index in pulmonary embolism. Eur Rev Med Pharmacol Sci 27(9):4108–4115
Rezaeimoghaddam M, van de Vosse FN (2022) Continuum modeling of thrombus formation and growth under different shear rates. J Biomech 132:110915
Senturk B, Akdeniz B, Yilmaz MB et al (2020) Whole blood viscosity in systemic sclerosis: a potential biomarker of pulmonary hypertension? Clin Rheumato 39(1):49–56. https://doi.org/10.1007/s10067-019-04603-4
Gok M, Kurtul A (2021) A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index. Scand Cardiovasc J 55(2):91–96
Cetin EHO, Ozbay MB, Cetin MS et al (2020) A new risk model for the evaluation of the thromboembolic milieu in patients with atrial fibrillation: the PALSE score. Kardiol Pol 78(7–8):732–740
Saliba W, Rennert G (2014) CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation. Am J Med 127(1):45–52
Abacioglu OO, Yildirim A, Karadeniz M et al (2022) A new score for determining thrombus burden in STEMI Patients: the MAPH score. Clin Appl Thromb Hemost 28:10760296211073768
Cakmak Karaaslan O, Çöteli C, Ozilhan MO et al (2022) The predictive value of MAPH score for determining thrombus burden in patients with non-ST segment elevation myocardial infarction. Egypt Heart J 74(1):60
Kucuk U, Altınsoy M (2023) Relationship of MAPH score with left ventricular apical trombus and adverse events in patients with acute anterior ST-elevation myocardial infarction. ABC Heart Fail Cardiomyop 3(3):e20230060
Tuzovic M, Adigopula S, Amsallem M et al (2016) Regional right ventricular dysfunction in acute pulmonary embolism: relationship with clot burden and biomarker profile. Int J Cardiovasc Imaging 32(3):389–398
Zhang H, Cheng Y, Chen Z et al (2022) Clot burden of acute pulmonary thromboembolism: comparison of two deep learning algorithms, Qanadli score, and Mastora score. Quant Imaging Med Surg 12(1):66–79
Hepburn-Brown M, Darvall J, Hammerschlag G (2019) Acute pulmonary embolism: a concise review of diagnosis and management. Intern Med J 49(1):15–27
Meyer HJ, Bailis N, Surov A (2021) Time efficiency and reliability of established computed tomographic obstruction scores in patients with acute pulmonary embolism. PLoS ONE 16(12):e0260802
Ząbczyk M, Natorska J, Janion-Sadowska A et al (2021) Loose fibrin clot structure and increased susceptibility to lysis characterize patients with central acute pulmonary embolism: the impact of isolated embolism. Thromb Haemost 121(4):529–537
Kupis RW, Goldman-Mazur S, Polak M et al (2019) Faster fibrin clot degradation characterizes patients with central pulmonary embolism at a low risk of recurrent peripheral embolism. Sci Rep 9(1):72
Gleditsch J, Jervan Ø, Klok F et al (2023) Does the clot burden as assessed by the mean bilateral proximal extension of the clot score reflect mortality and adverse outcome after pulmonary embolism? Acta Radiol Open 12(6):20584601231187096
Author information
Authors and Affiliations
Contributions
Conceptualization: OA, MK, TG, Data collection: OA, MB, Data analysis and investigation: OA, MK, TG Methodology: OA, MK, TG Reviewing-editing: OA, MK, TG, writing: OA, MB, MK, TG.
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that the study has no funding and conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Akhan, O., Boz, M., Guzel, T. et al. Discrimination of the acute pulmonary embolism subtypes based on the novel MAPH score. J Thromb Thrombolysis 57, 683–690 (2024). https://doi.org/10.1007/s11239-024-02952-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-024-02952-9